The BSE Sensex was down 435.27 points, or 2.25%, to 18623.04.

On BSE, 2.05 lakh shares of the scrip were traded. The stock had an average daily volume of 2.04 lakh shares on BSE in past one quarter.

The scrip had touched a high of Rs 92.50 and a low of Rs 76.05 so far during the day. The stock had hit a 52-week high of Rs 93.75 on 11 October 2007 and a 52-week low of Rs 50.50 on 14 March 2007.

The scrip had underperformed the market in the one month to 16 October 2007, adding 12.02% as against the Sensex's 22.88% gain. It had also underperformed the market in the past three months, gaining 5.86% against the Sensex's 24.51% rise.

The mid-cap drug maker has an equity capital of Rs 27.69 crore. Face value per share is Rs 2.

At the current price of Rs 88.90, the scrip trades at a PE multiple of 18.14, based on Q1 June 2007 annualised EPS of Rs 4.92.

The company said the land sale will be reflected in the financial results in the third quarter of the financial year 20O8

The company's net profit fell 6.6% to Rs 17.04 crore on 10% rise in sales to Rs 170.46 crore in Q1 June 2007 over Q1 June 2006.

Alembic develops, manufactures and markets pharmaceutical products, pharmaceutical substances and intermediates.